Login
Search result (1-13 of 13)Download
|
Symbol
|
RMAFAV | RMBIYV | RMBHTV | RMBPAV | RMBQSV | RMA6FV | RMBTIV | RMBB8V | RMBYFV | RMBMZV | RMBKMV | RMBGXV | RMAZHV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti |
|
Underlying
|
CREDIT SUISSE UBS MERGER / Ems-Chemie Hldg. AG / Sandoz Group AG | Baloise N / CREDIT SUISSE UBS MERGER / Geberit AG / Givaudan / SGS SA | CREDIT SUISSE UBS MERGER / Holcim/Amrize Basket / Sika AG | CREDIT SUISSE UBS MERGER / Galderma Group AG / Sonova Hldg. AG | CREDIT SUISSE UBS MERGER / DOCMORRIS AG / Galderma Group AG | Credit Suisse Group AG / Dufry AG / Julius Baer Group | Bayer AG / CREDIT SUISSE UBS MERGER / Ems-Chemie Hldg. AG | CREDIT SUISSE UBS MERGER / Givaudan / Holcim/Amrize Basket / Sika AG | CREDIT SUISSE UBS MERGER / Georg Fischer AG / Siegfried Hldg. AG | CREDIT SUISSE UBS MERGER / Ems-Chemie Hldg. AG / Lonza Group N | Adecco Group AG / Barry Callebaut AG / CREDIT SUISSE UBS MERGER / Kühne & Nagel Intl. AG | CREDIT SUISSE UBS MERGER / DOCMORRIS AG / Galenica AG | BASF SE / CREDIT SUISSE UBS MERGER / Ems-Chemie Hldg. AG / Givaudan |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
09.03.2026 | 23.02.2026 | 20.04.2026 | 27.04.2026 | 18.05.2026 | 29.12.2026 | 14.08.2026 | 08.03.2027 | 28.05.2026 | 07.12.2026 | 09.12.2026 | 14.09.2026 | 12.04.2027 |
| Bid | 64.70 | 59.20 | 58.20 | 57.90 | 33.900 | 95.90 | 89.20 | 83.20 | 91.40 | 92.30 | 97.00 | 99.00 | 97.50 |
| Ask | - | - | - | - | - | 96.70 | - | 84.00 | - | 93.10 | 97.80 | 100.00 | 98.30 |
Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.
Your Bookmarks (0)